Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 399)
Posted On: 10/28/2020 12:25:47 PM
Post# of 36567
Posted By: Paul Jackson
Posted by Generex on LinkedIn 23 minutes ago

While people exposed to #SARSCoV2 have been shown to acquire #immunity to the coronavirus for a few months, our Ii-key #vaccine aims to immunize against SARS-CoV-2 over a longer period by inducing long-term T-cell memory responses.

#sarscov2 #covid19 #immunology #immunotherapy #immunooncology #tcells #biotechnology #coronavirus #Iikeypeptide













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site